This study focuses on patients with severe burns affecting a large portion of the body surface. The research examines the effects of dexamethasone phosphate, a medication given through an intravenous line, along with sodium chloride solution. The purpose is to determine if dexamethasone can reduce serious complications and death rates in people with severe burn injuries.
The treatment involves receiving dexamethasone through a vein within the first two days after the burn injury occurs. The medication will be given for up to 5 days while patients are in the hospital under close medical supervision. During this time, patients will also receive standard burn care and treatment.
Throughout the study, doctors will monitor patients for various health issues that can occur after severe burns, including breathing problems and kidney function. They will also track other complications such as infections and wound healing. Patients will be followed for up to 90 days to assess their recovery and overall health outcomes.



France